A  	A  	 DT	O
menthol-based  	menthol-based  	 JJ	O
solid  	solid  	 JJ	O
dispersion  	dispersion  	 JJ	B-NP
technique  	technique  	 NN	I-NP
for  	for  	 IN	O
enhanced  	enhanced  	 JJ	O
solubility  	solubility  	 NN	B-NP
and  	and  	 CC	O
dissolution  	dissolution  	 NN	O
of  	of  	 IN	O
sulfamethoxazole  	sulfamethoxazole  	 NN	B-NP
from  	from  	 IN	O
an  	an  	 DT	O
oral  	oral  	 JJ	B-NP
tablet  	tablet  	 NNS	I-NP
matrix  	matrix  	 VBP	I-NP
A  	A  	 DT	O
menthol-based  	menthol-based  	 JJ	O
solid  	solid  	 JJ	O
dispersion  	dispersion  	 NN	O
was  	was  	 VBD	O
designed  	designed  	 VBN	O
to  	to  	 TO	O
improve  	improve  	 VB	O
the  	the  	 DT	O
intrinsic  	intrinsic  	 JJ	B-NP
solubility  	solubility  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
poorly  	poorly  	 RB	O
soluble  	soluble  	 JJ	O
sulfamethoxazole-  	sulfamethoxazole-  	 JJ	B-NP
a  	a  	 DT	I-NP
class  	class  	 NN	I-NP
II  	II  	 NNP	I-NP
drug  	drug  	 NN	I-NP
molecule  	molecule  	 NN	I-NP
of  	of  	 IN	O
Biopharmaceutics  	Biopharmaceutics  	 NNP	B-NP
Classification  	Classification  	 NNP	I-NP
System  	System  	 NNP	I-NP
( 	( 	 -LRB-	O
BCS 	BCS 	 NNP	B-NP
)  	)  	 -RRB-	O
displaying  	displaying  	 VBG	O
widespread  	widespread  	 JJ	O
antibacterial  	antibacterial  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Solid  	Solid  	 JJ	O
dispersions  	dispersions  	 NN	O
of  	of  	 IN	O
menthol  	menthol  	 NN	B-NP
and  	and  	 CC	O
sulfamethoxazole  	sulfamethoxazole  	 NNS	B-NP
were  	were  	 VBD	O
compressed  	compressed  	 VBN	O
with  	with  	 IN	O
hydroxypropyl  	hydroxypropyl  	 JJ	B-NP
methylcellulose  	methylcellulose  	 NNS	I-NP
( 	( 	 -LRB-	O
HPMC 	HPMC 	 NNP	B-NP
)  	)  	 -RRB-	O
into  	into  	 IN	O
suitable  	suitable  	 JJ	O
sulfamethoxazole-loaded  	sulfamethoxazole-loaded  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
tablets  	tablets  	 NNS	I-NP
for  	for  	 IN	I-NP
oral  	oral  	 JJ	I-NP
drug  	drug  	 NN	I-NP
delivery 	delivery 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
sulfamethoxazole-loaded  	sulfamethoxazole-loaded  	 JJ	B-NP
solid  	solid  	 JJ	O
dispersions  	dispersions  	 NN	O
and  	and  	 CC	O
compressed  	compressed  	 JJ	O
tablets  	tablets  	 NNS	O
were  	were  	 VBD	O
characterized  	characterized  	 VBN	O
for  	for  	 IN	O
their  	their  	 PRP$	O
physicochemical  	physicochemical  	 NN	B-NP
and  	and  	 CC	O
physicomechanical  	physicomechanical  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
crystallinity 	crystallinity 	 NN	B-NP
,  	,  	 ,	O
melting  	melting  	 VBG	B-NP
point 	point 	 NN	I-NP
,  	,  	 ,	O
molecular  	molecular  	 JJ	B-NP
transitions 	transitions 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
textural  	textural  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
for  	for  	 IN	I-NP
critical  	critical  	 JJ	I-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
their  	their  	 PRP$	O
effects  	effects  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
solubility  	solubility  	 NN	B-NP
and  	and  	 CC	O
dissolution  	dissolution  	 NN	O
of  	of  	 IN	O
sulfamethoxazole 	sulfamethoxazole 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
formulations  	formulations  	 NN	B-NP
were  	were  	 VBD	O
further  	further  	 RB	O
evaluated  	evaluated  	 VBN	O
for  	for  	 IN	O
swelling 	swelling 	 VBG	O
,  	,  	 ,	O
degradation 	degradation 	 NN	O
,  	,  	 ,	O
solubility 	solubility 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
drug  	drug  	 NN	I-NP
release  	release  	 NN	I-NP
behavior 	behavior 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
vitro  	vitro  	 JJ	B-NP
drug  	drug  	 NN	I-NP
release  	release  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
sulfamethoxazole-loaded  	sulfamethoxazole-loaded  	 JJ	B-NP
matrix  	matrix  	 JJ	I-NP
tablets  	tablets  	 NNS	I-NP
displayed  	displayed  	 VBD	O
a  	a  	 DT	O
minimum  	minimum  	 NN	O
and  	and  	 CC	O
maximum  	maximum  	 JJ	O
fractional  	fractional  	 JJ	B-NP
release  	release  	 NN	I-NP
of  	of  	 IN	O
0.714  	0.714  	 NNP	O
and  	and  	 CC	O
0.970 	0.970 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
tablets  	tablets  	 NNS	O
further  	further  	 RB	O
displayed  	displayed  	 VBN	O
different  	different  	 JJ	O
release  	release  	 NN	B-NP
rate  	rate  	 NN	I-NP
profiles  	profiles  	 NNS	I-NP
over  	over  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	B-NP
periods  	periods  	 NNS	I-NP
of  	of  	 IN	O
12 	12 	 CD	O
,  	,  	 ,	O
16 	16 	 CD	O
,  	,  	 ,	O
48 	48 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
56 h  	56 h  	 NNP	O
which  	which  	 WDT	O
were  	were  	 VBD	O
attributed  	attributed  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
varying  	varying  	 JJ	O
concentrations  	concentrations  	 NNS	B-NP
of  	of  	 IN	I-NP
menthol  	menthol  	 NN	I-NP
within  	within  	 IN	O
each  	each  	 DT	O
formulation 	formulation 	 NN	B-NP
.  	.  	 .	O
Menthol  	Menthol  	 NNP	B-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
suitable  	suitable  	 JJ	O
hydrophilic  	hydrophilic  	 JJ	B-NP
carrier  	carrier  	 NN	I-NP
for  	for  	 IN	I-NP
sulfamethoxazole  	sulfamethoxazole  	 NN	I-NP
since  	since  	 IN	O
it  	it  	 PRP	O
functioned  	functioned  	 VBD	O
as  	as  	 IN	O
a  	a  	 DT	O
solubilizing  	solubilizing  	 NN	B-NP
and  	and  	 CC	O
release-retarding  	release-retarding  	 JJ	O
agent  	agent  	 NN	B-NP
for  	for  	 IN	O
improving  	improving  	 VBG	O
the  	the  	 DT	O
solubility  	solubility  	 NN	B-NP
and  	and  	 CC	O
dissolution  	dissolution  	 NN	O
of  	of  	 IN	O
sulfamethoxazole  	sulfamethoxazole  	 NN	B-NP
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
controlling  	controlling  	 VBG	O
the  	the  	 DT	O
rate  	rate  	 NN	O
at  	at  	 IN	O
which  	which  	 WDT	O
it  	it  	 PRP	O
was  	was  	 VBD	O
released 	released 	 VBN	O
.  	.  	 .	O
